2025年2月4日 · Eprex 40000 IU/ml solution for injection in pre-filled syringe - Summary of Product Characteristics (SmPC) by Janssen-Cilag Ltd (a Johnson & Johnson Company)

2025年1月7日 · Eprex or exogenous epoetin alfa binds to the erythropoietin receptor (EPO-R) and activates intracellular signal transduction pathways . The affinity (Kd) of EPO for its receptor …

EPREX injection is a clear, colourless solution in prefilled syringes of 1000 IU in 0.5 mL, 2000 IU in 0.5 mL, 3000 IU in 0.3 mL, 4000 IU in 0.4 mL, 5000 IU in 0.5 mL, 6000 IU in 0.6 mL, 8000 …

Patient information for EPREX 4 000 IU/ML SOLUTION FOR INJECTION IN PFS Including dosage instructions and possible side effects.

EPREX should be used with caution in patients with epilepsy, history of seizures, or medical conditions associated with a predisposition to seizure activity such as CNS infections and …

© 2022 Janssen Inc., This site is published by Janssen Inc., which is solely responsible for its contents. Capitalized product names are trademarks of Janssen Inc ...

2019年7月12日 · 一项针对 120 名透析前慢性肾功能衰竭患者的 III 期研究评估了 Hemax PFS®（PFS：预装注射器）与创新促红细胞生成素 alfa 产品 (Eprex®) 的疗效和安全性。 本 …

Patient Information leaflet PRODUCT NAME EPREX (Epoetinum alfa) Pre-filled Syringe DOSAGE FORMS AND STRENGTHS Epoetinum alfa, a glycoprotein produced by …

2025年1月30日 · Eprex 10000 IU/ml solution for injection in pre-filled syringe - Patient Information Leaflet (PIL) by Janssen-Cilag Ltd (a Johnson & Johnson Company)

Patients with uncontrolled hypertension should not be treated with Eprex; blood pressure should be controlled adequately before initiation of therapy. Eprex should be used with caution in …